Experience

Business Generator Groningen

• Netherlands
• Research Services
• 1 - 100 Employee

• Business Developer

  • Sep 2021 - Present



Meducom

• Netherlands
• Professional Training and Coaching

• Associate Medical Director

  • 2016 - Present



Hero Biotechnology

• Biotechnology

• Founder and Chief Scientific Officer

  • Jun 2015 - Present

  Hero Biotechnology BV is dedicated to the development of new treatments for infectious diseases. The company is developing new drugs from research stage to clinical stage focusing on biologicals, especially fully human monoclonal antibodies. The lead compound, IQ-DAA, is a clinical stage antibody mixture for the treatment of inhalation anthrax. Hero Biotechnology BV is dedicated to the development of new treatments for infectious diseases. The company is developing new drugs from research stage to clinical stage focusing on biologicals, especially fully human monoclonal antibodies. The lead compound, IQ-DAA, is a clinical stage antibody mixture for the treatment of inhalation anthrax.



Omero Biosolutions BV

• Groningen, Netherlands

• Founder and Chief Scientific Officer

  • Dec 2012 - Present



Haisen Holding BV

• Groningen, Netherlands

• Founder

  • Oct 2012 - Present



Cerebro Biosolutions BV

• Netherlands
• Biotechnology Research

• Founder and Chief Scientific Officer

  • Jan 2015 - Dec 2020

  Cerebro Biosolutions wants to reduce Amyotrophic Lateral Sclerosis (ALS) to a chronic disease by impacting four important mechanisms underlying the development and progression of disease. Cerebro Biosolutions wants to reduce Amyotrophic Lateral Sclerosis (ALS) to a chronic disease by impacting four important mechanisms underlying the development and progression of disease.



Vaccinogen

• United States
• Biotechnology Research
• 1 - 100 Employee

• Global Manufacturing Director

  • Jul 2013 - Dec 2014

  Vaccinogen is a biotechnology company with more than three decades of research into combating cancer by using the body’s own immune system. It is the producer of OncoVAX®, an immunotherapy for Stage II colon cancer. OncoVAX® is currently manufactured in Emmen, the Netherlands. Vaccinogen is a biotechnology company with more than three decades of research into combating cancer by using the body’s own immune system. It is the producer of OncoVAX®, an immunotherapy for Stage II colon cancer. OncoVAX® is currently manufactured in Emmen, the Netherlands.



IQ Therapeutics

• Groningen Area, Netherlands

• Chief Scientific Officer

  • Sep 2004 - Jun 2012



IQ Corporation

• Research Services

• Manager R&D

  • Jun 2000 - Sep 2004



UMass Chan Medical School

• United States
• Higher Education
• 700 & Above Employee

• Visiting professor

  • May 1998 - Oct 1999



University of Groningen

• Netherlands
• Research Services
• 700 & Above Employee

• Researcher

  • 1988 - 1998

  Several research positions and tutor at the medical school Several research positions and tutor at the medical school